At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 10 enrolled
Drug / intervention
Collagenase Santyl Ointment +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Edge of Non-Healing Cutaneous Ulcers Following Debridement With Collagenase Santyl Ointment
In Brief
A Phase 4 clinical trial evaluating Collagenase Santyl Ointment and Placebo Comparator for Diabetic Foot Ulcers and Diabetic Foot Wounds. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The goal of this study is to evaluate changes in the healing tissue of diabetic foot wounds following 14 days of treatment with Santyl or its vehicle base.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcers, Diabetic Foot Wounds
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2010
Enrollment StartDec 2010
Primary CompletionApr 2012
Study CompletionOct 2012
TodayJul 2026
First PostedSep 9, 2010
Enrollment StartDec 1, 2010
Primary CompletionApr 1, 2012
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.8 years ago
Interventions
Collagenase Santyl Ointmentbiological
Topical daily application
Placebo Comparatorother
Topical daily application